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Coronary angiography provides detailed, dynamic images of
the coronary arterial lumens. These images provide an
explanation for angina and a roadmap to direct surgical or
catheter-based revascularization. Although a patient’s prog-
nosis is influenced by left ventricular systolic performance
and the number of stenosed coronary vessels, analysis of
stenosis severity alone does not accurately identify sites that
will subsequently occlude and produce a myocardial infarc-
tion (MI) (1). Because the consequences of MI are so
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important, additional means of evaluating the coronary
angiogram to accurately identify the lesions that will pro-
duce future events would be an important advance.
STENOSIS SEVERITY
When viewing a coronary angiogram, it is attractive to
assume that stenotic sites are at risk for thrombotic occlu-
sion that will produce MI, and that coronary arteries that do
not contain obstructive stenoses (,50%) are nearly free of
the risk of occlusion. However, this intuitively appealing
concept is flawed (1). Serial angiographic studies initially
reported both by our group (2) and by Ambrose et al. (3)
demonstrated that a coronary artery does not have to
contain an angiographically severe stenosis to suddenly
occlude and produce MI. In fact, most MI’s occur due to
occlusion of arteries that did not previously contain a
significant (.50%) stenosis, and the coronary artery that
previously contained the most severe stenosis is usually not
the culprit. These findings have been consistently confirmed
by the results of multiple serial angiographic studies (1).
This seemingly paradoxical finding can be understood by
examining the risk of subsequent occlusion and frequency of
stenotic and nonstenotic coronary artery segments. Seg-
ments of coronary arteries that contain a severe stenosis are
several-fold more likely to occlude than segments without a
stenosis. However, the risk of occlusion of the nonstenosed
segments is not zero, and they are far more numerous (4).
Thus, the bulk of occlusions occur in nonstenotic segments.
Cardiologists intuitively assign too high a risk of occlusion
to stenotic segments while underestimating the risk of
occlusion of nonstenotic segments. Furthermore, occlusions
of severely narrowed segments may not produce MI because
the preexistence of a stenosis acts as a stimulus for the
formation of protective collaterals.
Although coronary atherosclerosis produces its clinical
manifestations by narrowing or occluding the lumen, it is a
disease of the arterial wall. The initial response as athero-
sclerosis develops in the wall of the artery is usually an
outward expansion of the artery that accommodates the
atheroma while preserving the lumen (5). Typically, the
coronary lumen does not become narrowed until late in the
course of the disease. Thus, severe atherosclerosis may be
present even when only minimal luminal irregularities are
observed on an angiogram, and the rupture of a vulnerable
plaque can trigger thrombotic occlusion of an artery without
first narrowing the lumen. Consistent with this concept,
even patients with minor irregularities of the coronary artery
walls but without any angiographically significant stenosis
(,50% diameter narrowing), have a substantially lower
survival rate than patients with completely normal coronary
arteries (6). In addition, even minor changes in the severity
of narrowings may indicate active disease in the arterial wall
and are associated with the subsequent development of MI
(7).
STENOSIS MORPHOLOGY
Because stenosis severity does not adequately define the risk
of MI (2,3), subsequent studies have carefully evaluated
features of individual stenoses to characterize lesion specific
factors predisposing to thrombotic occlusion. The studies
have not yielded consistent findings. The fissured plaque
with overlying thrombus in patients with unstable angina,
non-Q wave MI or following thrombolytic therapy of MI
may be angiographically apparent as a convex, intraluminal
obstruction with overhanging edges, irregularities or in-
traluminal defects (8–10). The culprit lesions frequently
exhibit these angiographic characteristics after the develop-
ment of MI or unstable angina (8,10). Some studies suggest
that the more complex the morphology of the culprit
stenoses responsible for an unstable syndrome, the more
likely there will be further progression (11,12). It is possible
that stenoses with these characteristics in patients without
MI or unstable angina may have a higher risk of subsequent
occlusion (13), especially an occlusion that will produce a Q
wave MI (14). However, in other studies, the culprit plaque
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usually did not seem complex on angiograms performed
before the event (15,16). Similarly, the angiographic mor-
phology of the culprit lesion after thrombolytic therapy may
not predict subsequent reocclusion (17).
The article of Ledru et al. (18) expands our knowledge of
the angiographic characteristics of the culprit lesion before
MI. First, the findings of their serial angiographic study
again confirmed that a future culprit site is usually not
stenotic. (The mean stenosis of the culprit site before MI in
their study was 45%.) Second, they made the new observa-
tion that coronary artery narrowings with steeper outflow
angles were more likely to occlude. It is possible that this
relates to shear stress that might play a role in the distribu-
tion of inflammatory cells that may destabilize plaques (19).
Finally, Ledru et al. (18) made the surprising observation
that symmetrical narrowings are more likely to occlude than
eccentric lesions. This differs from the previous finding that
eccentric stenoses are an angiographic sign of an unstable or
ruptured plaque.
LIMITATIONS OF SERIAL ANGIOGRAPHIC STUDIES
All serial angiographic studies such as that by Ledru et al.
(18) have limitations, which Ledru et al. fully acknowledge.
First, the patients were highly selected and did not include
patients who did not have angiograms both before and
immediately after their MI. Thus, most patients with MI
would not have been included in this study, and no patients
with fatal MI’s were included. Second, only patients who
had MI were included. Thus, we do not know how many
lesions with the highest risk characteristics (severe symmet-
rical stenosis with steep outflow angle) will subsequently
occlude. Even in the study patients, all of whom had MI,
the positive predictive value of the highest risk stenosis that
was both concentric and with an abrupt angle was only 49%.
Moreover, 13% of the lowest risk areas subsequently oc-
cluded. It is also important to recognize that the “low” and
“moderate” risk areas were far more numerous than “high”
risk areas; thus, two-thirds of the MI’s occurred due to
occlusions of “low” and “moderate” risk areas. This limited
predictive power is similar to previous studies evaluating
lesion characteristics before MI.
The two-dimensional shadows of the arterial wall ob-
tained by coronary angiography provide only indirect and
limited information about the atherosclerotic process within
the arterial wall. No matter how well multiple angiographic
characteristics correlate with coronary occlusion, it seems
unlikely that coronary angiography will ever be able to
precisely define all potentially dangerous vulnerable plaques
within the arterial wall. It is possible that improved direct
imaging of coronary arterial wall with intravascular ultra-
sound or magnetic resonance imaging, or characterizing the
plaque by spectroscopy or thermal imaging will be more
successful in evaluating the status of disease within the wall
of the artery (20,21).
THERAPEUTIC IMPLICATIONS
The study by Ledru et al., (18) and others like it, point out
the limitation of using the coronary arteriogram to help
direct therapy aimed at preventing subsequent coronary
events. Coronary artery bypass surgery and percutaneous
transluminal coronary angioplasty are effective in eliminat-
ing ischemia when they are appropriately directed at angio-
graphically significant (i.e., stenotic or flow limiting) nar-
rowings. Because most occlusions occur at sites that did not
previously contain a flow limiting stenosis, these interven-
tions are not likely to be effective in preventing many
subsequent MIs (22).
Dilating or stenting a nonflow limiting area with angio-
graphic characteristics that suggest it may be a vulnerable
plaque is also unlikely to benefit the patient. First, the
absolute risk of subsequent occlusion of this site is low.
Second, dilation or stenting has not been proven to decrease
the risk of subsequent occlusion. Third, this strategy exposes
the patient to the risk of the procedure itself, as well as to
the risk of restenosis. If restenosis occurs, it can convert a
nonflow limiting area into an ischemia producing stenosis.
Although mechanical treatment of high-grade coronary
stenoses relieves angina and improves exercise tolerance,
slowing or reversing the progression of atherosclerosis in the
walls of the coronary arteries by altering serum lipids may be
a more powerful intervention to prevent the catastrophic
complications of coronary artery disease (unstable angina,
MI and death) (22). This concept is supported by the recent
preliminary report of the Atorvastatin Versus Revascular-
ization Trial (AVERT) study at the American Heart
Association meeting in Dallas.
CONCLUSIONS
In conclusion, coronary atherosclerosis is a disease of the
arterial wall that produces clinical manifestations by nar-
rowing the lumen. Angiographic imaging of the coronary
lumen provides an accurate assessment of the extent and
severity of atherosclerotic coronary narrowing. Although
angiographic correlates of vulnerable plaques that may
subsequently trigger MI have been described, the shadows
of the coronary lumen provide only indirect and incomplete
information concerning the extent, severity and activity of
the atherosclerosis process in the arterial walls. Thus,
coronary angiography cannot be expected to accurately
identify all plaques that are vulnerable or will become
vulnerable to rupture and subsequently produce an MI.
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